National Health Investors, Inc. (NYSE:NHI) has been assigned a consensus rating of “Hold” from the eight research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $79.25.
NHI has been the subject of several research analyst reports. Zacks Investment Research downgraded shares of National Health Investors from a “buy” rating to a “sell” rating in a research note on Tuesday, July 18th. Bank of America Corporation downgraded shares of National Health Investors from a “neutral” rating to an “underperform” rating and set a $76.00 price objective for the company. in a research note on Monday, May 22nd. BidaskClub downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Saturday, July 8th. Stifel Nicolaus upped their price objective on shares of National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Wednesday, June 21st. Finally, ValuEngine downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th.
National Health Investors (NYSE:NHI) traded up 0.06% during mid-day trading on Wednesday, hitting $80.64. The stock had a trading volume of 184,911 shares. National Health Investors has a 52-week low of $66.31 and a 52-week high of $81.29. The firm has a 50-day moving average of $78.17 and a 200-day moving average of $75.79. The stock has a market cap of $3.31 billion, a P/E ratio of 20.71 and a beta of 0.56.
National Health Investors (NYSE:NHI) last released its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company had revenue of $69.84 million during the quarter, compared to analyst estimates of $67.68 million. During the same quarter in the prior year, the company earned $1.22 EPS. The business’s revenue was up 14.1% on a year-over-year basis. On average, analysts forecast that National Health Investors will post $3.85 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be paid a $0.95 dividend. The ex-dividend date is Thursday, September 28th. This represents a $3.80 annualized dividend and a yield of 4.71%. National Health Investors’s dividend payout ratio is presently 97.69%.
TRADEMARK VIOLATION WARNING: This report was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://sportsperspectives.com/2017/09/11/national-health-investors-inc-nhi-given-average-rating-of-hold-by-brokerages.html.
In other news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares in the company, valued at $1,693,994.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 5.19% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Carroll Financial Associates Inc. acquired a new stake in shares of National Health Investors during the second quarter worth about $158,000. Yorktown Management & Research Co Inc acquired a new stake in shares of National Health Investors during the second quarter worth about $214,000. Allegis Investment Advisors LLC acquired a new stake in shares of National Health Investors during the second quarter worth about $216,000. Quantbot Technologies LP acquired a new stake in shares of National Health Investors during the first quarter worth about $201,000. Finally, Profund Advisors LLC boosted its stake in shares of National Health Investors by 4.3% during the second quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock worth $248,000 after buying an additional 130 shares during the period. Institutional investors and hedge funds own 70.58% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.